The purpose of this study is to provide participants diagnosed with obsessive compulsive disorder (OCD) and completed one of the active study protocols at the Rodriguez Lab, with open/aftercare treatment.
After completing one of the active clinical studies participants have the option to enroll in this protocol that offers open treatment. The goal is to compare two forms of current standard treatments, psychotherapy vs pharmacotherapy.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
200
Evidenced based psychotherapy by a trained psychologist
Pharmacotherapy by a psychiatrist
Stanford University
Stanford, California, United States
Improvement in the severity of OCD symptoms as measured by the Yale-Brown Obsessive Compulsive Scale (YBOCS)
Improvement in OCD severity is measured by the YBOCS (Yale Brown Obsessive-Compulsive Scale), a gold standard measure of obsessions and compulsions. For the YBOCS the minimum units are 0 and Maximum units on the total scale are 40. The higher the number on the YBOCS, the more severe the symptoms. Response is defined as at least a 35% reduction on the YBOCS.
Time frame: Up to 14 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.